Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Cardium Therapeutics Inc CRXM
(Total Views: 364)
Posted On: 07/10/2020 6:56:55 AM
Post# of 72
Posted By: docj
Re: Bravo16 #17
https://clinicaltrials.gov/ct2/show/NCT029280...amp;rank=1


So many variables. First Q of 2023 based on the above info. having said that the trial could be stopped early if the interim data is good. Considering there is unmet need it could be approved immediately without the normal 10 month FDA review or even without having to be fast tracked at 6 months.


Glad you stopped in here for a visit. I appreciate your insight on the GNBT board. Don't forget the CC this afternoon! We are expecting information on the new subsidiary NuGenerex Immuno-Oncology.

More to follow on CRXM.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site